Waqaas AlSiddiq - Biotricity Founder, Chairman, CEO and Executive Officer

Chairman

Mr. Waqaas AlSiddiq is Founder, Chairman, Chief Executive Officer and Executive Officer of the Company. Mr. Waqaas, the founder of biotricity, is a serial entrepreneur, a former investment advisor and an expert in wireless communication technology. Academically, he was distinguished for his various innovative designs in digital, analog, embedded, and microelectromechanical products. His work was published in various conferences such as IEEE and the National Communication Council. Mr. Waqaas has held several highlevel design positions in IBM, AMD, and Intel. His achievements have been numerous in both the technical and academic world. Coupled with this, Waqaas has vast experience in leading various groups through his board experience executive roles within startups, midsized companies, and nonprofits since 2016.
Age 39
Tenure 9 years
Phone(800) 590-4155
Webhttps://www.biotricity.com
Waqaas has a dual Bachelor’s degree in Computer Engineering and Economics, a Master’s in Computer Engineering from Rochester Institute of Technology, and a Master’s in Business Administration from Henley Business School. He is completing his Doctorate in Business Administration at Henley, with a focus on Transformative Innovations and Billion Dollar Markets.

Waqaas AlSiddiq Latest Insider Activity

Tracking and analyzing the buying and selling activities of Waqaas AlSiddiq against Biotricity stock is an integral part of due diligence when investing in Biotricity. Waqaas AlSiddiq insider activity provides valuable insight into whether Biotricity is net buyers or sellers over its current business cycle. Note, Biotricity insiders must abide by specific rules, including filing SEC forms every time they buy or sell Biotricity'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Biotricity Management Efficiency

The company has return on total asset (ROA) of (0.8862) % which means that it has lost $0.8862 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (41.0079) %, meaning that it created substantial loss on money invested by shareholders. Biotricity's management efficiency ratios could be used to measure how well Biotricity manages its routine affairs as well as how well it operates its assets and liabilities.
Biotricity currently holds 23.88 M in liabilities with Debt to Equity (D/E) ratio of 6.45, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Biotricity has a current ratio of 1.51, which is within standard range for the sector. Note, when we think about Biotricity's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 2 records

CHAIRMAN Age

Zackary IraniBiomerica
59
Paul DiPernaModular Medical
66
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. Biotricity operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 44 people. Biotricity (BTCY) is traded on NASDAQ Exchange in USA. It is located in 203 Redwood Shores Parkway, Redwood City, CA, United States, 94065 and employs 55 people. Biotricity is listed under Medical Equipment category by Fama And French industry classification.

Management Performance

Biotricity Leadership Team

Elected by the shareholders, the Biotricity's board of directors comprises two types of representatives: Biotricity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biotricity. The board's role is to monitor Biotricity's management team and ensure that shareholders' interests are well served. Biotricity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biotricity's outside directors are responsible for providing unbiased perspectives on the board's policies.
Fareeha Siddiqui, Senior Solutions
Amjad Talpur, Senior Operations
George Nikopoulos, Director Development
Waqaas AlSiddiq, Founder, Chairman, CEO and Executive Officer
Amir Ali, Chief Officer
John Ayanoglou, Chief Officer
Andy Wong, Vice Operations
Matt Zabel, Vice Strategy

Biotricity Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biotricity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Consideration for investing in Biotricity Stock

If you are still planning to invest in Biotricity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotricity's history and understand the potential risks before investing.
Stocks Directory
Find actively traded stocks across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins